期刊
ANAESTHESIA
卷 67, 期 9, 页码 991-998出版社
WILEY-BLACKWELL
DOI: 10.1111/j.1365-2044.2012.07197.x
关键词
-
资金
- MSD
- GlaxoSmithKline
Deep neuromuscular blockade during certain surgical procedures may improve operating conditions. Sugammadex can be used to reverse deep neuromuscular blockade without waiting for spontaneous recovery. This randomised study compared recovery times from neuromuscular blockade induced by rocuronium 0.6 mg.kg-1, using sugammadex 4 mg.kg-1 administered at 12 post-tetanic count (deep blockade) or neostigmine 50 mu g.kg-1 (plus atropine 10 mu g.kg-1) administered at the re-appearance of the second twitch of a train-of-four stimulation (moderate blockade), in patients undergoing laparoscopic surgery. The primary efficacy variable was the time from the start of sugammadex/neostigmine administration to recovery of the train-of-four ratio to 0.9. Patients receiving sugammadex recovered 3.4 times faster than patients receiving neostigmine (geometric mean (95% CI) recovery times of 2.4 (2.12.7) and 8.4 (7.29.8) min, respectively, p < 0.0001). Moreover, 94% (62/66) of sugammadex-treated patients recovered within 5 min, vs 20% (13/65) of neostigmine-treated patients, despite the difference in the depth of neuromuscular blockade at the time of administration of both drugs. The ability to provide deep neuromuscular blockade throughout the procedure but still permit reversal at the end of surgery may enable improved surgical access and an enhanced visual field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据